BIND

11 Biotechnology Stocks to Sell Now

By Portfolio Grader
For the current week, the overall ratings of 11 biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Why 3D Systems, Global Payments and BIND Therapeutics Are 3 of Today’s Best Stocks

By Ethan Roberts, InvestorPlace Contributor
The bulls are once more firmly in control of Wall Street, and 3D Systems, Global Payments, and BIND Therapeutics were three of Thursday's best stocks.